The continually expanding toolkit from Mohit Verma's laboratory at Purdue University now includes a portable, paper-based ...

The submitted test runs on the firm's point-of-care instrument and detects four respiratory pathogens within 10 minutes directly from patient nasal swab samples.

JN.1-adapted COVID-19 vaccines were effective against hospitalization and mortality for at least 4 months among older adults.

The impact of timely respiratory diagnosis in decentralized care settings As hospitals and health systems across the nation gear up for another potentially unpredictable respiratory season, the ...

Molbio Diagnostics, winner of the businessline Changemaker award 2024, files for IPO with revolutionary Truenat platform for ...

A new study has found that a common nasal spray, azelastine, could help prevent COVID. In this interview, Katia Hetter/CNN ...

Importance Little research has been done on post-COVID symptoms at 24 months postinfection and on the association these may ...

A common nasal spray may lower the risk of getting Covid-19, a new study shows. Dr. Leana Wen discusses what this all means as coronavirus cases rise.

Amid the uncertainty surrounding eligibility for and access to the latest Covid-19 vaccine, a new study has found that a ...

Azooka Labs, founded by molecular biologist Dr Fathima Benazir and her childhood friend-turned-co-founder Alex D. Paul, is ...

The FDA has accepted for review the NDA for ensitrelvir for the prevention of COVID-19 following exposure to an infected individual.

Qiagen N.V. ( NYSE: QGEN) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 1:05 PM EDT ...